Dr. David Earl Schultz
Claim this profileQualmedica Research, LLC
Studies Diabetes
Studies Type 2 Diabetes
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials David Earl Schultz is currently running
Tirzepatide
for Obesity
This trial is testing tirzepatide, a medication that helps control blood sugar and reduce appetite, to see if it can lower health problems and death rates in adults who are very overweight. Tirzepatide was developed by Eli Lilly to improve blood sugar control in adults with type 2 diabetes.
Recruiting1 award Phase 39 criteria
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
More about David Earl Schultz
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Earl Schultz has experience with
- Tirzepatide
- Placebo
- Insulin Efsitora Alfa
- Insulin Degludec
- Antihyperglycemic Medication
- Orforglipron
Breakdown of trials David Earl Schultz has run
Diabetes
Type 2 Diabetes
Endocrine Disorders
Metabolic Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Earl Schultz specialize in?
David Earl Schultz focuses on Diabetes and Type 2 Diabetes. In particular, much of their work with Diabetes has involved treating patients, or patients who are undergoing treatment.
Is David Earl Schultz currently recruiting for clinical trials?
Yes, David Earl Schultz is currently recruiting for 3 clinical trials in Evansville Indiana. If you're interested in participating, you should apply.
Are there any treatments that David Earl Schultz has studied deeply?
Yes, David Earl Schultz has studied treatments such as Tirzepatide, Placebo, Insulin Efsitora Alfa.
What is the best way to schedule an appointment with David Earl Schultz?
Apply for one of the trials that David Earl Schultz is conducting.
What is the office address of David Earl Schultz?
The office of David Earl Schultz is located at: Qualmedica Research, LLC, Evansville, Indiana 47715 United States. This is the address for their practice at the Qualmedica Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.